Revenue | ₹5.16Cr |
Net Profits | ₹0.01Cr |
Net Profit Margins | 0.19% |
Beryl Drugs Ltd’s revenue fell -8.67% since last year same period to ₹5.16Cr in the Q2 2025-2026. On a quarterly growth basis, Beryl Drugs Ltd has generated 6.61% jump in its revenue since last 3-months.
Beryl Drugs Ltd’s net profit jumped 0% since last year same period to ₹0.01Cr in the Q2 2025-2026. On a quarterly growth basis, Beryl Drugs Ltd has generated -50% fall in its net profits since last 3-months.
Beryl Drugs Ltd’s net profit margin jumped 9.5% since last year same period to 0.19% in the Q2 2025-2026. On a quarterly growth basis, Beryl Drugs Ltd has generated -53.1% fall in its net profit margins since last 3-months.
The revenue for Beryl Drugs Ltd in the Q2 results 2025 was ₹5.16Cr.
The net profit for Beryl Drugs Ltd in the Q2 results 2025 was ₹0.01Cr.
The net profit margin for Beryl Drugs Ltd in the Q2 results 2025 was 0.19%.
The revenue for Beryl Drugs Ltd in the Q2 results 2024 was ₹5.65Cr.
The net profit for Beryl Drugs Ltd in the Q2 results 2024 was ₹0.01Cr.
The net profit margin for Beryl Drugs Ltd in the Q2 results 2024 was 0.18%.